PRP and the FDA: How Advertising Claims Can Trigger Regulatory Risk for Regenerative Clinics
News & Posts PRP and the FDA: How Advertising Claims Can Trigger Regulatory Risk for Regenerative Clinics PRP therapy is often viewed as presenting lower
PRP Malpractice Trends in 2026: The Changing Landscape of Complication Claims
News & Posts PRP Malpractice Trends in 2026: The Changing Landscape of Complication Claims In 2026, the landscape of PRP malpractice is evolving, marked by